Co-Authors
This is a "connection" page, showing publications co-authored by Guangming Ye and Yirong Li.
Connection Strength
1.406
-
High Performance of SARS-Cov-2N Protein Antigen Chemiluminescence Immunoassay as Frontline Testing for Acute Phase COVID-19 Diagnosis: A Retrospective Cohort Study. Front Med (Lausanne). 2021; 8:676560.
Score: 0.239
-
Aberrant cytokine expression in COVID-19 patients: Associations between cytokines and disease severity. Cytokine. 2021 07; 143:155523.
Score: 0.234
-
Environmental contamination of SARS-CoV-2 in healthcare premises. J Infect. 2020 08; 81(2):e1-e5.
Score: 0.220
-
Asymptomatic SARS-CoV-2 Infection in Household Contacts of a Healthcare Provider, Wuhan, China. Emerg Infect Dis. 2020 08; 26(8):1930-1933.
Score: 0.220
-
Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation. J Infect. 2020 05; 80(5):e14-e17.
Score: 0.218
-
Serum-soluble ST2 as a novel biomarker reflecting inflammatory status and illness severity in patients with COVID-19. Biomark Med. 2020 12; 14(17):1619-1629.
Score: 0.057
-
Positive RT-PCR Test Results in Patients Recovered From COVID-19. JAMA. 2020 04 21; 323(15):1502-1503.
Score: 0.055
-
Re: Profile of specific antibodies to SARS-CoV-2: The first report. J Infect. 2020 07; 81(1):e80-e81.
Score: 0.055
-
RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak. Emerg Microbes Infect. 2020; 9(1):313-319.
Score: 0.054
-
Can routine laboratory tests discriminate SARS-CoV-2-infected pneumonia from other causes of community-acquired pneumonia? Clin Transl Med. 2020 Jan; 10(1):161-168.
Score: 0.054